Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: A review of diagnosis and management

C. J. Saphier, J. T. Repke

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Abstract

Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome is a form of severe preeclampsia that threatens the gravida and her fetus. In this report, the diagnostic criteria and maternal and fetal risks of HELLP are defined. Prompt recognition and treatment in tertiary centers is emphasized, because the prognosis can be adversely affected by delayed or less than optimal diagnosis and treatment. Management guidelines are offered for treating disorder. The potential roles of corticosteroids, plasmapheresis, and expectant management are critically evaluated. Subsequent pregnancy outcome, contraception, and preventative strategies are considered.

Original languageEnglish (US)
Pages (from-to)118-133
Number of pages16
JournalSeminars in Perinatology
Volume22
Issue number2
DOIs
StatePublished - 1998

All Science Journal Classification (ASJC) codes

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: A review of diagnosis and management'. Together they form a unique fingerprint.

Cite this